BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30445944)

  • 21. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.
    Munagala R; Kausar H; Munjal C; Gupta RC
    Carcinogenesis; 2011 Nov; 32(11):1697-705. PubMed ID: 21859835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines.
    Miyamoto Y; Nakagawa S; Wada-Hiraike O; Seiki T; Tanikawa M; Hiraike H; Sone K; Nagasaka K; Oda K; Kawana K; Nakagawa K; Fujii T; Yano T; Kozuma S; Taketani Y
    Oncol Rep; 2013 Jan; 29(1):51-7. PubMed ID: 23064281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mass spectrometry-based approach for the identification of Kpnβ1 binding partners in cancer cells.
    Okpara MO; Hermann C; van der Watt PJ; Garnett S; Blackburn JM; Leaner VD
    Sci Rep; 2022 Nov; 12(1):20171. PubMed ID: 36418423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells.
    Xia J; Yu X; Song X; Li G; Mao X; Zhang Y
    Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells.
    Miyamoto T; Kashima H; Yamada Y; Kobara H; Asaka R; Ando H; Higuchi S; Ida K; Mvunta DH; Shiozawa T
    PLoS One; 2016; 11(5):e0155220. PubMed ID: 27168162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
    Liu X; Yang WT; Zheng PS
    Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eps8 decreases chemosensitivity and affects survival of cervical cancer patients.
    Chen YJ; Shen MR; Chen YJ; Maa MC; Leu TH
    Mol Cancer Ther; 2008 Jun; 7(6):1376-85. PubMed ID: 18566210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear import of exogenous FGF1 requires the ER-protein LRRC59 and the importins Kpnα1 and Kpnβ1.
    Zhen Y; Sørensen V; Skjerpen CS; Haugsten EM; Jin Y; Wälchli S; Olsnes S; Wiedlocha A
    Traffic; 2012 May; 13(5):650-64. PubMed ID: 22321063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel trifluoromethyl benzopyran induces G1 cell cycle arrest and apoptosis in HeLa human cervical carcinoma cells.
    Zhang X; Hwang J; Jia X; Shin DS; You S; Kim DK
    Int J Oncol; 2013 Aug; 43(2):469-76. PubMed ID: 23708884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
    Shehata M; Shehata M; Shehata F; Pater A
    Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of cell proliferation by the opioid growth factor receptor is dependent on karyopherin beta and Ran for nucleocytoplasmic trafficking.
    Cheng F; McLaughlin PJ; Zagon IS
    Exp Biol Med (Maywood); 2010 Sep; 235(9):1093-101. PubMed ID: 20705629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin restores p53 function and enhances the radiosensitivity in HPV16 E6 containing SiHa cells.
    Huang H; Huang SY; Chen TT; Chen JC; Chiou CL; Huang TM
    J Cell Biochem; 2004 Mar; 91(4):756-65. PubMed ID: 14991767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin Modulates Cyclin D1 and P53 Expression to Inhibit Cell Proliferation and to Induce Apoptosis in Cervical Cancer Cell Lines.
    Yudhani RD; Astuti I; Mustofa M; Indarto D; Muthmainah M
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1667-1673. PubMed ID: 31244286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of p16(ink4a) inhibits cell proliferation and induces G1 cell cycle arrest in cervical cancer cells.
    Zhang CY; Bao W; Wang LH
    Int J Mol Med; 2014 Jun; 33(6):1577-85. PubMed ID: 24714974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin I promotes cisplatin resistance via Cdk5 activation in cervical cancer.
    Li R; Liu GZ; Luo SY; Chen R; Zhang JX
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4533-41. PubMed ID: 26698249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
    Tao T; Yang X; Qin Q; Shi W; Wang Q; Yang Y; He J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
    Pavan S; Olivero M; Corà D; Di Renzo MF
    Eur J Cancer; 2013 Mar; 49(4):964-73. PubMed ID: 23079474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of mTOR signaling pathway contributes to survival of cervical cancer cells.
    Ji J; Zheng PS
    Gynecol Oncol; 2010 Apr; 117(1):103-8. PubMed ID: 20102778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diallyl sulfide induces cell cycle arrest and apoptosis in HeLa human cervical cancer cells through the p53, caspase- and mitochondria-dependent pathways.
    Wu PP; Chung HW; Liu KC; Wu RS; Yang JS; Tang NY; Lo C; Hsia TC; Yu CC; Chueh FS; Lin SS; Chung JG
    Int J Oncol; 2011 Jun; 38(6):1605-13. PubMed ID: 21424116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.